White paper
Bridging the gap:
Addressing unmet needs in cardiology, neuroscience and respiratory trials
Improve clinical trial feasibility with patient-centered strategies to reduce screen failures, support enrollment and strengthen outcomes.
Cardiology, neuroscience and respiratory trials face persistent feasibility challenges, driven by complex protocols, restrictive eligibility criteria and misalignment with real-world care. These factors continue to slow enrollment, increase screen failure rates and limit meaningful outcomes for sponsors.
In this white paper, you’ll discover
- How patient burden, data variability and operational complexity impact study success and why more pragmatic, patient-centered approaches are essential.
- When common diseases behave like rare ones.
- Why eligibility criteria remain at odds with clinical realities.
- More about subjectivity, adherence and uncontrollable variables.
- How digital tools and artificial intelligence (AI) improve feasibility and efficiency.
- How Trialmed provides a solution by translating these insights into action.
Uncover actionable strategies that can help accelerate enrollment, reduce screen failures and improve trial performance across complex indications.
Improve Trial Feasibility, Download the White Paper.